載入...
CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma
BACKGROUND: Calmodulin1 (CALM1) has been identified as one of the overexpression genes in a variety of cancers and EGFR inhibitor have been widely used in clinical treatment but it is unknown whether CALM1 and epidermal growth factor receptor (EGFR) have a synergistic effect in esophageal squamous c...
Na minha lista:
| 發表在: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7890995/ https://ncbi.nlm.nih.gov/pubmed/33602237 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01801-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|